PPh3 Research Articles

Reversible ligand exchange of triphenylphosphine with thiols on gold nanoparticles for Janus modification and catalyst recycling

Separation and regeneration of ultrafine catalysts in reaction system still remain challenging. In this study, we demonstrate a simple route to recycle gold nanoparticle (Au NP) catalysts by alternating surface wettability. Hydrophilic Au NPs protected with 3-mercapto-1,2-propanediol (MPD) were applied to catalyze the reduction of 4-nitrophenol (4-NP) using sodium borohydride as reductant, and were then separated from the suspension by interfacial ligand exchange with a toluene solution containing triphenylphosphine (TPP), led to amphiphilic Janus Au NPs with both MPD and TPP ligands at the toluene-water interface. The catalyst was regenerated by a reversible ligand exchange with a MPD aqueous solution. Experiments show that interfacial ligand exchange between phosphines and thiols on gold surface is reversible, although the forward and backward rates are different. As a result, the Au NP catalyst capped with MPD exhibited an excellent catalytic activity with an apparent rate constant (k) of 2.79 min−1, and the performance could be maintained for more than 10 regeneration cycles. The facile conversion between hydrophilic and amphiphilic Janus Au NPs provides a new pathway to explore monophasic and multiphasic reactions with convenient catalyst separation and regeneration.

Metal−Organic Precursors for Transition‐Metal‐Doped Ni2P via Pyrolysis for Efficient Overall Water Splitting and Supercapacitance

AbstractThe synthesis of solvent‐less bare‐surface nickel phosphides is desired, considering their superior electrocatalytic properties and straightforward synthetic protocols compared to their analogues prepared from colloidal routes. Herein, we report the synthesis of [Ni{S2P(OH)(4‐CH3OC6H4)}2] (1), [Fe{S2P(OH)(4‐CH3OC6H4)}3] (2) and [Co{S2P(OC4H9)(4‐CH3OC6H4)}3] (3) and their utilization to form Ni2P, Fe‐Ni2P and Co‐Ni2P in a solvent‐less pyrolysis method. This solvent‐free protocol involved the decomposition of complex (1) and the composites of complex (1) with (2) or (3) in the presence of triphenylphosphine (TPP) at 400 °C for one hour. The solvent‐less decomposition of complex (1) without TPP formed nickel sulfide. A plausible explanation for this rare fabrication of pristine and doped Ni2P in the absence of any solvent is suggested. All the transition metal doped phosphides improved the HER performance of pristine Ni2P, with the 5 % Fe doped Ni2P having the best performance, requiring 137 mV to reach a current density of 10 mA/cm2. Similarly, the OER performance of un‐doped Ni2P was improved by all the doped Ni2P catalysts, where 10 % Fe‐doped Ni2P showed the best performance requiring 326 mV to reach a current density of 10 mA/cm2. Transition metal doping was also shown to improve the reaction kinetics, stability and durability of the solvent‐free prepared Ni2P.

Methionine-Containing Peptides: Avoiding Secondary Reactions in the Final Global Deprotection.

The solid-phase synthesis of Met-containing peptides using a fluorenylmethoxycarbonyl (Fmoc)/tert-butyl (tBu) protection scheme is inevitably accompanied by two stubborn side reactions, namely, oxidation and S-alkylation (tert-butylation), which result in the formation of Met(O) and sulfonium salt impurities of the target peptide, respectively. These two reactions are acid-catalyzed, and they occur during the final trifluoroacetic (TFA)-based acidolytic cleavage step. Herein, we developed two new cleavage solutions that eradicate the oxidation and reduce S-alkylation. TFA-anisole-trimethylsilyl chloride (TMSCl)-Me2S-triisopropylsilane (TIS) containing 1 mg of triphenyl phosphine per mL of solution was the optimal mixture for Cys-containing peptides, while for the remaining peptides, TIS was not required. Both cleavage solutions proved to be excellent when sensitive amino acids such as Cys and Trp were involved. TMSCl did not affect either of these sensitive amino acids. Reversing the sulfonium salt to free Met-containing peptide was achieved by heating the peptide at 40 °C for 24 h using 5% acetic acid.

Formulation and evaluation of a two-stage targeted liposome coated with hyaluronic acid for improving lung cancer chemotherapy and overcoming multidrug resistance

Multidrug resistance (MDR) has emerged as a prominent challenge contributing to the ineffectiveness of chemotherapy in treating non-small cell lung cancer (NSCLC) patients. Currently, mitochondria of cancer cells are identified as a promising target for overcoming MDR due to their crucial role in intrinsic apoptosis pathway and energy supply centers. Here, a two-stage targeted liposome (HA/TT LP/PTX) was successfully developed via a two-step process: PTX-loaded cationic liposome (TT LP/PTX) were formulated by lipid film hydration & ultrasound technique, followed by further coating with natural anionic polysaccharide hyaluronic acid (HA). TT, an amphipathic polymer conjugate of triphenylphosphine (TPP)-tocopheryl polyethylene glycol succinate (TPGS), was used to modify the liposomes for mitochondrial targeting. The average particle size, zeta potential and encapsulation efficiency (EE%) of HA/TT LP/PTX were found to be 153 nm, −30.3 mV and 92.1% based on the optimal prescription of HA/TT LP/PTX. Compared to cationic liposome, HA-coated liposomes showed improved stability and safety, including biological stability in serum, cytocompatibility, and lower hemolysis percentage. In drug-resistant A549/T cells, HA was shown to improve the cellular uptake of PTX through CD44 receptor-mediated endocytosis and subsequent degradation by hyaluronidase (HAase) in endosomes. Following this, the exposure of TT polymer facilitated the accumulation of PTX within the mitochondria. As a result, the function of mitochondria in A549/T cells was disturbed, leading to an increased ROS level, decreased ATP level, dissipated MMP, and increased G2/M phase arrest. This resulted in a higher apoptotic rate and stronger anticancer efficacy.

Electrochemical Reduction of Quaternary Phosphonium Derivatives: A Systematic Optimization Approach

Triphenylphosphine (TPP) is one of the crucial reagents in Wittig olefination reactions. As part of the reaction, TPP will be sacrificed to yield the desired olefin (E/Z) as well as triphenylphosphine oxide (TPPO) containing a strong oxygen–phosphorus double bond (P═O). TPPO is considered thermodynamically stable but economically undesired. Conventional chemical recycling methods to reduce PV to PΙΙΙ utilize sacrificial reduction agents (silanes, boranes, and allanes). In recent years, many studies have focused on less toxic and sacrificial-agent-free alternative pathways. This study focuses on the optimization of an indirect electrochemical reduction of TPPO toward TPP, which becomes possible after the activation of TPPO with methyl triflate. Under optimized conditions, the P═O bond of TPPO is weakened to allow a current efficiency of up to 50% and a chemical selectivity of 99%.

Molecular Influences on the Quantification of Lewis Acidity with Phosphine Oxide Probes.

Gutmann-Beckett-type measurements with phosphine oxide probes can be used to estimate effective Lewis acidity with 31P nuclear magnetic resonance spectroscopy, but the influence of the molecular structure of a given probe on the quantification of Lewis acidity remains poorly documented in experimental work. Here, a quantitative comparison of triethyl (E), trioctyl (O), and triphenyl (P) phosphine oxides as molecular probes of Lewis acidity has been carried out via titration studies in MeCN with a test set of six mono- and divalent metal triflate salts. In comparison to E, the bulkier O displays a similar range of chemical shift values and binding affinities for the various test metal ions. Spectral linewidths and speciation properties vary for individual cation-to-probe ratios, however, confirming probe-specific properties that can impact the data quality. Importantly, P displays a consistently narrower dynamic range than both E and O, illustrating how electronic changes at phosphorus can influence the NMR response. Comparative parametrizations of the effective Lewis acidities of a broader range of metal ions, including the trivalent rare earth ions Y3+, Lu3+, and Sc3+ as well as the uranyl ion (UO22+), can be understood in light of these results, providing insight into the fundamental chemical processes underlying the useful approach of single-point measurements for quantification of effective Lewis acidity. Together with a study of counteranion effects reported here, these data clarify the diverse ensemble of factors that can influence the measurement of Lewis acid/base interactions.

Preparation and Performance of a Self-Produced High-Molecular-Weight Waterborne Epoxy–Acrylic Emulsion

To improve the stability of waterborne epoxy–acrylic emulsions and their comprehensive properties, such as the chemical resistance of coatings, a new research idea is proposed in this paper. First, a series of high-molecular-weight epoxy resins were synthesized with epoxy resin E-51 and bisphenol A (BPA) using benzyl triphenyl phosphine bromide as the catalyst. Then, free-radical graft copolymerization was carried out between the epoxy resin and methacrylic acid (MAA), styrene (ST), and butyl acrylate (BA) using benzoyl peroxide (BPO) as the initiator. This method ensured that the epoxy groups were retained. Finally, the carboxylic acid groups were neutralized with N,N-dimethylethanolamine (DMEA), and a stable aqueous epoxy–acrylic emulsion was obtained by high-speed dispersion in deionized water. The effects of key factors such as temperature, time, the molecular weight and dosage of epoxy resin, the dosage of MAA, the dosage of BPO, and the neutralization degree of the synthesis of emulsions and coating film properties were mainly discussed. The molecular weight and molecular weight distribution of the epoxy resin were determined by gel permeation chromatography (GPC). The epoxy resin and its graft copolymer were analyzed and characterized by Fourier-transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA). The particle size and distribution of the emulsions were tested by laser particle size analysis. The morphology of the emulsion particles was observed by transmission electron microscopy. The results showed that the acrylic monomers (MAA, ST, and BA) were grafted onto the epoxy resin. The graft copolymers showed higher glass transition temperatures compared with those of the pure epoxy resin. TGA showed that the graft copolymer started to decompose at a high temperature before the pure epoxy resin did, and the thermal stability was slightly reduced. The prepared emulsions with a particle size of 160 nm had a storage stability of more than one year and showed excellent dilution stability, mechanical stability, and freeze–thaw stability. The emulsions were coated and cured at 150 °C for 1 h with a pencil hardness of 5 H, an adhesion of grade 1, and a flexibility of 1 mm. The water resistance was >60 days, the salt water resistance was >30 days, the acid resistance was >10 days, and the alkali resistance was >5 days.

Mitochondrial Calcium Nanoregulators Reverse the Macrophage Proinflammatory Phenotype Through Restoring Mitochondrial Calcium Homeostasis for the Treatment of Osteoarthritis.

Osteoarthritis (OA) is a chronic degenerative joint disease accompanied by an elevated macrophage proinflammatory phenotype, which is triggered by persistent pathologically elevated calcium ion levels in mitochondria. However, existing pharmacological compounds targeting the inhibition of mitochondrial calcium ion (m[Ca2+]) influx are currently limited in terms of plasma membrane permeability and low specificity for ion channels and transporters. In the present study, we synthesized mesoporous silica nanoparticle-amidated (MSN)-ethylenebis (oxyethylenenitrilo)tetraacetic acid (EGTA)/triphenylphosphine (TPP)-polyethylene glycol (PEG) [METP] nanoparticles (NPs), which specifically target mitochondria and block excess calcium ion influx. m[Ca2+] overload in OA mouse bone marrow-derived macrophages (BMDMs) was detected by a fluorescence probe. A tissue in situ fluorescence colocalization assay was used to evaluate METP NP uptake by macrophages. BMDMs from healthy mice were pretreated with a concentration gradient of METP NPs followed by lipopolysaccharide (LPS) stimulation and detection of m[Ca2+] levels in vitro. The optimal METP NP concentration was further applied, and the endoplasmic reticulum (ER) and cytoplasm calcium levels were detected. The inflammatory phenotype was measured by surface markers, cytokine secretion and intracellular inflammatory gene/protein expression. A Seahorse cell energy metabolism assay was performed to elucidate the mechanism by which METP NPs reverse the BMDM proinflammatory phenotype. The present study identified calcium overload in BMDM mitochondria of OA mice. We demonstrated that METP NPs reversed the increased m[Ca2+] levels in mitochondria and the proinflammatory phenotype of BMDMs, with both in vivo and in vitro experiments, via the inhibition of the mitochondrial aspartate-arginosuccinate shunt and ROS production. We demonstrated that METP NPs are effective and highly specific regulators of m[Ca2+] overload. In addition, we demonstrated that these METP NPs reverse the macrophage proinflammatory phenotype by restoring m[Ca2+] homeostasis, thereby inhibiting the tissue inflammatory response and achieving a therapeutic effect for OA.

Exploring Rhenium Arene Piano-Stool Chemistry with [Re(η6-C6H6)(NCCH3)3]+: A Powerful Semi-Solvated Precursor.

Thermal treatment of the ReIII hydride complex [ReH(η5-C6H7)(η6-C6H6)]+ in CH3CN results in the formation of [Re(η6-C6H6)(NCCH3)3]+. This semi-solvated complex is remarkably stable under an ambient atmosphere and exhibits a fast CH3CN self-exchange, which facilitates substitution reactions. The CH3CN ligands are replaced by σ-donating phosphines such as trimethyl phosphine (PMe3), triphenyl phosphine (PPh3), or the bidentate 1,2-bis(diphenylphosphino)ethane (dppe) to afford [Re(η6-C6H6)(NCCH3)3-x(PR3)x]+ (if R = Me, then x = 2; if R = Ph, then x = 1 or 2) or [Re(η6-C6H6)(dppe)(NCCH3)]+, respectively. [Re(η6-C6H6)(NCCH3)3]+ also reacts with π-acceptors such as 2,2'-bipyridine (bipy), 1,10-phenanthroline (phen), or CO (1 atm) to give [Re(η6-C6H6)(L)(NCCH3)]+ (L = bipy or phen) and [Re(η6-C6H6)(CO)(NCCH3)2]+, respectively. The latter does not show any signs of decomposition after being exposed to an ambient atmosphere for multiple days. Additionally, [Re(η6-C6H6)(NCCH3)3]+ reacts with π-donors such as the dienes 2,3-dimethyl-1,3-butadiene (DMBD), norbornadiene (NBD), or 1,5-cyclooctadiene (COD) to give [Re(η6-C6H6)(η4-diene)(NCCH3)]+ (diene = DMBD, NBD, and COD). All three complexes are extremely stable and do not decompose during purification by preparative high-performance liquid chromatography (aqueous acidic gradient). In the presence of 18-crown-6, [Re(η6-C6H6)(NCCH3)3]+ reacts with lithium cyclopentadienyl to give the sandwich complex [Re(η5-C5H5)(η6-C6H6)]. Loss of the coordinated benzene was observed when treating [Re(η6-C6H6)(NCCH3)3]+ with diphenylacetylene (PhC≡CPh), yielding the tetra-coordinated [Re(NCCH3)(η2-PhC≡CPh)3]+.

Application Prospects of Triphenylphosphine-Based Mitochondria-Targeted Cancer Therapy.

Cancer is one of the leading causes of death and the most important impediments to the efforts to increase life expectancy worldwide. Currently, chemotherapy is the main treatment for cancer, but it is often accompanied by side effects that affect normal tissues and organs. The search for new alternatives to chemotherapy has been a hot research topic in the field of antineoplastic medicine. Drugs targeting diseased tissues or cells can significantly improve the efficacy of drugs. Therefore, organelle-targeted antitumor drugs are being explored, such as mitochondria-targeted antitumor drugs. Mitochondria is the central site of cellular energy production and plays an important role in cell survival and death. Moreover, a large number of studies have shown a close association between mitochondrial metabolism and tumorigenesis and progression, making mitochondria a promising new target for cancer therapy. Combining mitochondrial targeting agents with drug molecules is an effective way of mitochondrial targeting. In addition, hyperpolarized tumor cell membranes and mitochondrial membrane potentially allow selective accumulation of mitochondria-targeted drugs. This enhances the direct killing of tumor cells by drug molecules while minimizing the potential toxicity to normal cells. In this review, we discuss the common pro-mitochondrial agents, the advantages of triphenylphosphine (TPP) in mitochondrial-targeted cancer therapy and systematically summarize various TPP-based mitochondria-targeting anticancer drugs.

Mitochondrial-targeting Mn3O4/UIO-TPP nanozyme scavenge ROS to restore mitochondrial function for osteoarthritis therapy.

Excessive reactive oxygen species (ROS)-induced mitochondrial damage has impact on osteoarthritis (OA). Nanozyme mimics as natural enzyme alternatives to scavenge excessive ROS has offered a promising strategy for OA therapy. Herein, we reported a novel mitochondrial-targeting Mn3O4/UIO-TPP nanozyme using metal-organic frameworks with loaded Mn3O4 as the enzyme-like active core combining mitochondria-targeting triphenylphosphine (TPP) groups to serve as ROS scavengers for therapy of OA. With sequential catalysis of superoxide dismutase-like, catalase (CAT)-like, and hydroxyl radical (·OH) scavenging potentials, the nanozyme can target mitochondria by crossing subcellular barriers to effectively eliminate ROS to restore mitochondrial function and inhibit inflammation and chondrocyte apoptosis. It also has favorable biocompatibility and biosafety. Based on anterior cruciate ligament transection-induced OA joint models, this mitochondrial-targeting nanozyme effectively mitigated the inflammatory response with the Pelletier score reduction of 49.9% after 8-week therapy. This study offers a prospective approach to the design of nanomedicines for ROS-related diseases.

Impact of added ligand oxides in the sulfoxidation of phenylmercaptoacetic acids with oxovanadium(IV)‐salen complexes

AbstractThe mechanistic aspects covering the effect of added ligand oxides, picoline N‐oxide (PicNO), pyridine N‐oxide (PyNO), and triphenyl phosphine oxide (TPPO) on the selective sulfoxidation of phenylmercaptoacetic acids to PSAA by H2O2 catalyzed by oxovanadium(IV)‐salen complexes have been studied spectrophotometrically in 100% acetonitrile medium. Hydroperoxovanadium(V)‐salen is the reactive species in this sulfoxidation. The rate of sulfoxidation is found to be enhanced significantly by increasing the concentrations of PMAA, salen, and H2O2. The ascertained order of reactivity among the oxovanadium(IV)‐salen complexes is 5,5′‐dimethyl > unsubstituted salen > 5,5′‐dichloro. The reaction is found to be impeded by the addition of ligand oxide and introduction of substituents in PMAA. The observed order of rate retardation among ligand oxides is TPPO < PyNO < PicNO. Downward Hammett plot obtained has been rationalized by change in rate‐determining step from coordination of PMAA to active species for electron‐withdrawing substituents to transfer of oxygen to PMAA for electron‐donating substituents within the same mechanism.

Studies on anticancer properties with varying co-ligands in a Ru(II) arene benzimidazole system.

Recently in the field of chemotherapeutics, to combat the side effects of cisplatin, ruthenium complexes have been investigated extensively. In this work, a bidentate benzimidazole-based ligand, HL [HL = 2-(1H-benzo[d]imidazol-2-yl)-6-methoxyphenol], was utilized to obtain three Ru(II) arene complexes having a generalized formula [Ru(η6-p-cym)(L)(X)] or [Ru(η6-p-cym)(L)(X)]+ (where p-cym = p-cymene). The co-ligand X (X = (i) Cl, (ii) PPh3 = triphenyl phosphine, and (iii) PTA = 1,3,5-triaza-7-phosphaadamantane) was varied in order to study the effect it has on the antitumor activity of the compounds. The synthesized compounds were thoroughly characterized using different analytical techniques, including ESI-MS, NMR, FTIR, UV-Vis, and fluorescence spectroscopy. A fluorescence quenching experiment with serum albumin proteins revealed good interactions between the complexes and HSA and BSA. An analysis of their lipophilic character via the shake flask method and a stability study using UV spectroscopy were conducted as well. The anticancer properties of the synthesized compounds were further explored by conducting a DNA binding study using absorption spectroscopy and fluorometric titration with DAPI to check the mode of binding with DNA. Interestingly, the complexes were also found to catalyze the oxidation of NADH to NAD+, giving rise to radical species in the cells. An immunoblot analysis strongly suggested that all three complexes can remarkably upregulate the expression of cleaved caspase-3 and downregulate the expression of the anti-apoptotic protein BCLXL. It is important to note that such studies are yet to be reported for similar benzimidazole-based ruthenium complexes and therefore present a new direction for the investigation of antitumor ruthenium-based metallodrugs. Furthermore, Hoechst and AO/EtBr staining was used to analyze the morphological changes of the compound-treated cancer cells due to apoptosis, which was also confirmed by the IC50 values obtained from the colorimetric assay (MTT) against different cancer cell lines.

Self-reported and self-facilitated theranostic oxygen nano-economizer for precise and hypoxia alleviation-potentiated photodynamic therapy.

Photodynamic therapy (PDT) has been extensively investigated for cancer treatment by virtue of singlet oxygen-induced oxidative damage to tumors. Nevertheless, the therapeutic efficiency of PDT is still limited by the low singlet oxygen yield attributed to the improper irradiation duration and the tumor hypoxic microenvironment. To tackle these challenges, we elaborately design a theranostic oxygen nano-economizer to self-report the optimal irradiation duration and alleviate tumor hypoxia simultaneously, which is engineered by fluorescent 9,10-anthracenyl bis (benzoic acid) (DPA)-MOF, tetrakis (4-carboxyphenyl) porphyrin (TCPP), triphenyl phosphine (TPP) and redox-responsive lipid-PEG (DSPE-SS-PEG2k). Upon laser irradiation, the fluorescence of DPA-MOF could be quenched, thereby self-reporting the optimal irradiation duration for sufficient PDT. The decoration of DSPE-SS-PEG2k and TPP endows the theranostic oxygen nano-economizer with a tumor-specific response and mitochondrial targeting capability, respectively. Notably, singlet oxygen generated from TCPP reduces oxygen consumption by disrupting the entire oxidative phosphorylation (OXPHOS) pathway in the mitochondria of tumor cells, further improving the level of singlet oxygen in a self-facilitated manner for hypoxia alleviation-potentiated PDT. As expected, such a self-reported and self-facilitated theranostic oxygen nano-economizer exhibits potent antitumor activity in the 4T1 tumor-bearing mouse model. This study offers a theranostic paradigm for precise and hypoxia alleviation-potentiated cancer therapy.

Ligand-assisted morphology regulation of AuNi bimetallic nanocrystals for efficient hydrogen evolution.

We report the controllable synthesis of AuNi core-shell (c-AuNi) and Janus (j-AuNi) nanocrystals (NCs) with uniform shape, tunable size and compositions in the presence of trioctylphosphine (TOP) or triphenylphosphine (TPP). The morphology of the AuNi bimetallic NCs could be regulated by varying the structure and concentration of phosphine ligands. The ligand-directed structural evolution mechanism of AuNi bimetallic NCs was investigated and discussed in detail. When loaded on graphitic carbon nitride (GCN) for photocatalytic hydrogen generation, the obtained j-AuNi NCs showed much higher activity for hydrogen evolution than the monometallic (Au and Ni) counterparts, owing to the synergistic effect of plasmon enhanced light absorption from the Au portion and additional electron sink effect from the Ni portion. This work provides a promising route for preparing low-cost Au-based bimetallic catalysts with controllable morphologies and high activities for hydrogen production.

Triphenylphosphine oxide promoting visible-light-driven C-C coupling via desulfurization.

Triphenylphosphine oxide (TPPO) and triphenylphosphine (TPP) can form a complex in solution, promoting visible light absorption to trigger electron transfer within the complex and generate radicals. Subsequent radical reactions with thiols enable desulfurization to produce carbon radicals that react with aryl alkenes to yield new C-C bonds. Since ambient oxygen can easily oxidize TPP to TPPO, the reported method requires no explicit addition of a photocatalyst. This work highlights the promise of using TPPO as a catalytic photo-redox mediator in organic synthesis.

Mitochondrion-targeting and in situ photocontrolled protein delivery via photocages.

Defects in mitochondrial proteostasis contribute to many disorders, including cancer, neurodegeneration, and metabolic and genetic diseases. A strategy aimed at restoring the damaged mitochondrial proteostasis is the mitochondrion-targeting and carrier-free delivery of exogenous functional proteins that can replace the endogenous dysfunctional proteins. The modification of a protein with a photolabile protecting group (PPG, i.e., photocage group) can be activated in situ by response to illumination, leading to release of the protein from its photocage. Here, the Cys and peptide photocages with coumarin were first prepared and characterized for proof of concept. Then, we designed a pair of photocage groups PPG-RhB and PPG-TPP using coumarin and mitochondrion-targeting Rhodamine B (RhB) and triphenylphosphine (TPP), and another pair of organelle-nontarget photocage groups Br-PPG and NO2-PPG for comparison. The proteins modified with these two pairs of photocage groups undergo photolysis in solutions, and can penetrate cell membrane toward their destinations in the carrier-free fashions. The intracellular protein photocages are in situ activated by illumination at 405nm, and the proteins are released from their photocages in mitochondria and cytoplasm, respectively. This strategy of light-responsive and carrier-free cellular delivery enables mitochondrial and cytoplasmic accumulation of exogenous proteins.

Glutathione-sensitive mesoporous nanoparticles loaded with cinnamaldehyde for chemodynamic and immunological therapy of cancer.

Chemodynamic therapy as a novel type of chemotherapy can damage the DNA structures and induce cell apoptosis and immunogenic cell death (ICD) through generating reactive oxygen species (ROS) to aggravate oxidative stress. Nonetheless, as an intrinsic antioxidative response of tumor cells, the expression of glutathione (GSH) can be upregulated to maintain the cellular redox balance and protect the tumor cells from ROS-mediated damage. In this context, it is feasible to simultaneously boost ROS generation and GSH depletion in tumor cells; however, the precise delivery and release of GSH scavengers at specific subcellular sites is of great importance. Herein, we propose a GSH-responsive mesoporous organosilica nanoparticle (MON)-based nanomedicine MON-CA-TPP@HA through sequentially covalently attaching triphenylphosphine (TPP) and electrostatically coating hyaluronic acid (HA) onto the surface of cinnamaldehyde (CA)-loaded MONs, known as MON-CA-TPP@HA, which has been demonstrated to be an extremely effective therapeutic strategy for cancer treatment through inducing ICD and apoptosis of breast cancer cells. Systematic in vitro experimental results clearly revealed that the nanomedicine can actively target the tumor cells with the help of HA, subsequently enter the tumor cells, and precisely bind with the mitochondria through TPP residues. Upon cleavaging the disulfide bond in the MONs triggered by over-expressed GSH within tumors, the CA molecules can be released inducing the excessive ROS in situ surrounding the mitochondria to activate oxidative stress to induce apoptosis and ICD of breast cancer cells. The results of the in vivo experiments confirm that the MON-CA-TPP@HA nanomedicine can effectively promote dendritic cell (DC) maturation and CD 8+ T cell activation and regulate the ratio of M1/M2 macrophages, which improve tumor immunosuppressive microenvironment. It is thus believed that the current nanomedicine has paved a new way for future cancer therapy.

Preparation of porous organic polymers containing N or P atoms and their application in hydroformylation of 1-octene

Three kinds of porous organic polymers (POPs) containing N or P atoms were prepared, named N-POP, P-POP, and N + P-POP respectively and used as the supports for Rh catalysts. Their structures and compositions were fully understood by FTIR, XRD, EDX, 13C MAS NMR, 31P MAS NMR and XPS characterizations. Rich micropores and mesopores were detected in the polymers through N2 adsorption–desorption, SEM and TEM. Because of the bulk extrusion of triphenylphosphine (TPP) unit in Rh-P-POP and Rh-N + P-POP, the Rh-N-POP showed a larger BET surface area and larger pore volume. The characterization also proved that P atoms were oxidized partly to PO species. Their catalysis performances were tested in the hydroformylation of 1-octene and syngas, with isomerization as the main competing reaction. It was interesting to see that the inactive Rh-N-POP allowed Rh to combine with free ligands more easily, thus promoting the hydroformylation activity. The existence of TPP structure in the polymers, however, greatly promoted isomerization, with a weak hydroformylation activity, partly due to the partial oxidation of P atoms. On the other hand, the strong alkalinity and coordination ability of P atoms in the polymers made the association and dissociation of Rh with other free ligands difficult.

Electronic Tuning of Gold Nanoparticle Active Sites for Reduction Catalysis.

Electronic tuning of active sites in heterogeneous catalysis with organic ligands remains challenging since the ligands are often bound to the most active sites on the catalysts' surfaces. In this work, gold nanoparticles, which are on average less than 2 nm in diameter, are synthesized with strongly binding thiol and phosphine ligands and have measurable quantities of accessible sites on their surfaces in both cases. Triphenylphosphine (TPP) is used as the phosphine ligand, while triphenylmethyl mercaptan (TPMT) serves as the thiol ligand. Phosphines are chosen because they are electron-donating ligands when bound to Au, and thiols are selected because they are electron-withdrawing on the Au surface. X-ray photoelectron spectroscopy (XPS) results show differences in the Au 4f binding energies between the TPP- and TPMT-bound Au nanoparticles. Fourier transform infrared spectroscopy (FTIR) measurements of bound CO indicate that the TPP-bound Au nanoparticles are more electron-rich than the TPMT-bound Au nanoparticles. The number of binding sites on the surface is quantified using 2-naphthalenethiol titration experiments. It is observed that the number of binding sites on the thiol and phosphine-bound Au nanoparticles is similar in both cases. The Au nanoparticles are used for three different reactions: resazurin reduction, CO oxidation, and benzyl alcohol oxidation. For both CO oxidation and benzyl alcohol oxidation, which are performed with the ligands attached, TPP- and TPMT-bound nanoparticles are both catalytically active. However, for resazurin reduction, the TPMT-bound Au nanoparticles are not active, while the TPP-bound Au nanoparticles are catalytically active. These results illustrate that the catalytic activity can be tuned using bound organic ligands with different electronic properties for reduction reactions using Au nanoparticle catalysts.